TM38837
Product Specifications
UNSPSC Description
CB1 antagonist 4 is a inverse agonist of cannabinoid receptor 1 (CB1) with an IC50 of 0.4 nM. CB1 antagonist 4 can reduce body weight, improve plasma inflammatory markers and glucose homeostasis[1].
Target Antigen
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/tm38837-1.html
Solubility
10 mM in DMSO
Smiles
FC(F)(C1=CC=C([C@@H](C)NC(C2=NN(C3=CC=CC=C3Cl)C(C4=CC=C(Cl)C=C4)=C2CC5=NNN=N5)=O)C=C1)F
Molecular Weight
586.40
References & Citations
[1]Högberg T, et al. Optimizing and characterizing 4-methyl substituted pyrazol-3-carboxamides leading to the peripheral cannabinoid 1 receptor inverse agonist TM38837. Bioorg Med Chem Lett. 2023 Dec 1;98:129572.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-157312/TM38837-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-157312/
Clinical Information
Phase 1
CAS Number
1034264-77-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Diethyl spiro[3.3]heptane-2,6-dicarboxylate](https://cdn.genprice.uk/genprice/genprice5.png)
